Providers in the United States may now order the FDA-cleared HPV self-collection solution for their patients to use in their offices or other healthcare settings, with goal to reduce barriers to screening by enabling discreet self-collectionQuest also plans to make self-collection option available at its 2,000 patient service centers in the United States early next month, expanding access to screeningNew solution follows company's launch of GTI self-collection option for several STIs and related conditions ...